Fourth International Conference on Cancer and the Heart

At the conclusion of this educational activity, participants should be able to

–Outline the individual and combinations of anti-cancer agents and understand the short and long term toxic effect on the heart (knowledge, competence);

–Identify cardiovascular structures at risk and mechanisms of damage for treatment and prevention of cardiotoxicity (knowledge);

–Demonstrate diagnostic and treatment strategies for heart failure, as well as ischemic heart disease, arrhythmias, thromboembolism, and hypertension in cancer patients (knowledge, competence);

–Incorporate the role of different imaging technologies for assessment of cardiovascular problems in cancer patients to improve care, including: MRI, Echocardiography, strain rate imaging and carotid stenosis monitoring (knowledge, competence, performance, patient outcomes);

–Implement recent scientific advances in managing risk factors for the prevention of cardiotoxicity, such as hypertension, diabetes coronary artery disease, peripheral vascular disease, dyslipidemia. (knowledge, competence, performance, patient outcomes)

Back to top